马俊杰
开通时间:..
最后更新时间:..
点击次数:
发表刊物:Future Medicinal Chemistry
论文类型:期刊论文
卷号:14
页面范围:1681-1692
是否译文:否
发表时间:2022-11-01
收录刊物:SCI
DOI码:10.4155/fmc-2022-0188
影响因子:4.2
上一条:Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostat
下一条:Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020